---
title: Profil World - The clinical diabetes research newsletter - October 2021
description: "Latest \"Profil World\" edition about our free online seminar on oral insulins and a study on semaglutide versus placebo reduced liver steatosis."
image: https://blog.profil.com/hubfs/Header_1077x400px_520x272_About_Profil_edited.jpg
---

[![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com)

<https://www.profil.com/en/search>

[![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da)

[Patient information](https://www.profil.de)

![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg")

# Profil World - The clinical diabetes research newsletter - October 2021

![Maria](https://blog.profil.com/hubfs/Maria_Hexagon.png)

Posted by [Maria Andresen](https://blog.profil.com/blog/author/maria-andresen)  on Oct 13, 2021 2:16:34 PM

![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.")

![Two clicks for more privacy: The Twitter Share button will be enabled once you click here.
                          Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here.
                            Activating the button already sends data to Twitter.")

Dear all,

Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

### Free live online seminar: Advancements in oral insulin development: are we nearly there yet?

[![Oral_Insulins](https://blog.profil.com/hs-fs/hubfs/CTAs/Webinar_Bilder/Oral_Insulins.png?width=215&name=Oral_Insulins.png)](https://info.profil.com/free-online-seminar-oral-insulins) Join us for our next free live online seminar titled: "Advancements in oral insulin development: are we nearly there yet?". It will take place on November 2nd at 4 PM CEST. Dr. Eric Zijlstra, Executive Project Director at Profil, will be presenting the insights into this topic. [Register here.](https://info.profil.com/free-online-seminar-oral-insulins)

 

 

 

### EU Clinical Trials Regulation (EU-CTR) enters application on 31 January 2022

[![EU Clinical trial regulation](https://blog.profil.com/hs-fs/hubfs/calender-angepasst.jpg?width=215&name=calender-angepasst.jpg)](https://blog.profil.com/blog/eu-clinical-trial-regulation-enters-application)On the 2nd of August 2021 EMA published the start of the countdown to go-live for the Clinical Trials Information System (CTIS). The Clinical Trials Regulation aims to harmonise the submission, assessment and supervision processes for clinical trials throughout the EU. In this blog post, we’ll have a look at the applicable timelines for the next years and EMA´s training and support plan. Read more [here](https://blog.profil.com/blog/eu-clinical-trial-regulation-enters-application).

 

### Semaglutide versus placebo as regards non-alcoloholic fatty liver desease

[![Profil Publication](https://blog.profil.com/hs-fs/hubfs/0090_RGB__.jpg?width=210&name=0090_RGB__.jpg)](https://pubmed.ncbi.nlm.nih.gov/34570916/)[Read our publication](https://pubmed.ncbi.nlm.nih.gov/34570916/) semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging.  
If you are interested in our other publications please [click here](https://www.profil.com/knowledge-center/publications).

 

 

Meet us at upcoming virtual conferences in 2021 and 2022

[![Fotolia_14.06.2013_23704610__](https://blog.profil.com/hs-fs/hubfs/Fotolia_14.06.2013_23704610__.jpg?width=210&name=Fotolia_14.06.2013_23704610__.jpg)](https://info.profil.com/meet-profil-at-a-conference)

Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to [schedule a meeting](https://info.profil.com/meet-profil-at-a-conference?hsCtaTracking=63e44b5d-b4df-4c1f-b703-140f9d7e4b5a%7C7c52721e-ab74-4343-8377-f34ad168b5e0) and tell you more about our expertise! Upcoming events:

[BIO Europe Digital](https://informaconnect.com/bioeurope/?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-8sS5s4_OBmYDethhA9PTktGyoxUQisSgiLb01pvYIWSshL2Er9krc6dug7joTW1WcGkZ9O), October 21-28, 2021  
[Biotech Showcase](https://informaconnect.com/biotech-showcase/?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-8sS5s4_OBmYDethhA9PTktGyoxUQisSgiLb01pvYIWSshL2Er9krc6dug7joTW1WcGkZ9O), January 11-15, 2022

 

We wish you a good week and look forward to the next "Profil World",

Maria Andresen - Marketing Manager 

 

 Topics: [About Profil](https://blog.profil.com/blog/topic/about-profil)

[Leave a comment](https://blog.profil.com/blog/profil-world-newsletter-2021-october#comment_form)

### Subscribe to Email Updates

### Our most popular Posts

### Posts by Topic

- [Clinical Trials in Diabetes (127)](https://blog.profil.com/blog/topic/clinical-trials-in-diabetes)
- [About Profil (69)](https://blog.profil.com/blog/topic/about-profil)
- [Clinical Trial Methods (68)](https://blog.profil.com/blog/topic/clinical-trial-methods)
- [The Science behind Diabetes (64)](https://blog.profil.com/blog/topic/the-science-behind-diabetes)
- [Treating Diabetes (62)](https://blog.profil.com/blog/topic/treating-diabetes)
- [Diabetes Technology (41)](https://blog.profil.com/blog/topic/diabetes-technology)
- [Clinical trials in Obesity (11)](https://blog.profil.com/blog/topic/clinical-trials-in-obesity)
- [Events (4)](https://blog.profil.com/blog/topic/events)
- [CRO selection (2)](https://blog.profil.com/blog/topic/cro-selection)
- [Regulatory Affairs (2)](https://blog.profil.com/blog/topic/regulatory-affairs)

[see all](https://blog.profil.com/blog/profil-world-newsletter-2021-october#)

## You might also like this post

### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)